- £8.14bn
- £5.77bn
- £24.64bn
- 61
- 78
- 60
- 78
Annual balance sheet for Centrica, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,673 | 4,625 | 4,287 | 6,744 | 6,223 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,576 | 4,884 | 7,095 | 4,890 | 4,764 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 10,412 | 19,885 | 20,688 | 16,066 | 14,144 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,643 | 1,985 | 1,748 | 1,846 | 1,859 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 17,119 | 27,086 | 29,038 | 21,366 | 18,733 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7,665 | 17,976 | 21,711 | 11,136 | 8,902 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 16,162 | 24,721 | 28,021 | 17,489 | 14,311 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 957 | 2,365 | 1,017 | 3,877 | 4,422 |
Total Liabilities & Shareholders' Equity | 17,119 | 27,086 | 29,038 | 21,366 | 18,733 |
Total Common Shares Outstanding |